MARKET

FLDM

FLDM

Fluidigm
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.94
-0.21
-2.94%
After Hours: 7.02 +0.08 +1.15% 19:12 10/20 EDT
OPEN
7.08
PREV CLOSE
7.15
HIGH
7.20
LOW
6.72
VOLUME
1.87M
TURNOVER
--
52 WEEK HIGH
12.45
52 WEEK LOW
1.170
MARKET CAP
494.94M
P/E (TTM)
-8.9237
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Co-Diagnostics: Diversified In COVID-19 Diagnostics
"The misfortune of some makes the happiness of others" goes an old saying.In this case, high COVID-19 infection rates have been a boon for companies like Co-Diagnostics and their investors.Further rise in infection rates may just be the trigger needed to boost the stock price but beware, as there are others in the same business too.Moreover, despite a lawsuit filed against CODX, the company's Logix testing kit is still present in the FDA's list.Given the high percentage of a short position, it would be better to be on the sidelines and wait for an update concerning the lawsuit.
Seekingalpha · 9h ago
Fluidigm Shares +18.5% Premarket; Trump Administration Announced Friday it was Providing Co's Saliva Test at Surge Testing Site in Waco, TX
https://www.hhs.gov/about/news/2020/10/16/trump-administration-provides-saliva-test-at-surge-testing-site-in-waco-tx.html
Benzinga · 1d ago
Fluidigm Soars 16% As Covid-19 Saliva Test Selected In US; Analyst Sees 78% Upside
SmarterAnalyst · 2d ago
Fluidigm +14% after COVID-19 test offered in federal program
Fluidigm (FLDM) flies after-hours as the U.S. Department of Health & Human Services says the federal surge testing effort for COVID-19 will offer the company's saliva test which uses samples
Seekingalpha · 4d ago
FISV, TCOM, FLDM and SELB among after-hours movers
Gainers: [[ALGS]] +17.2%. [[FLDM]] +11.1%. [[SELB]] +9%. [[SOS]] +5.2%. [[PSNL]] +4%.Losers: [[TCOM]] -8.5%. [[FISV]] -6%. [[SCS]] -5.4%. [[LOOP]] -5.4%. [[AGIO]] -4.4%.
Seekingalpha · 4d ago
Investors Who Bought Fluidigm (NASDAQ:FLDM) Shares A Year Ago Are Now Up 63%
It's been a soft week for Fluidigm Corporation (NASDAQ:FLDM) shares, which are down 19%. But that doesn't change the...
Simply Wall St. · 5d ago
Should I Buy Fluidigm Corporation (FLDM)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
Insider Monkey · 10/13 00:30
30-second coronavirus test could help out the travel sector and more
A rapid coronavirus detection test that gives results in under a minute - developed by Israel and India - should be ready in "a matter of days," according to Israeli
Seekingalpha · 10/11 11:24
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of FLDM. Analyze the recent business situations of Fluidigm through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average FLDM stock price target is 14.00 with a high estimate of 16.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 176
Institutional Holdings: 63.46M
% Owned: 88.98%
Shares Outstanding: 71.32M
TypeInstitutionsShares
Increased
35
5.14M
New
50
6.00M
Decreased
40
12.81M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.48%
Healthcare Equipment & Supplies
-0.72%
Key Executives
Chairman/Independent Director
Carlos Paya
President/Chief Executive Officer/Director
Stephen Linthwaite
Chief Financial Officer
Vikram Jog
Senior Vice President/General Counsel/Secretary
Nicholas Khadder
Senior Vice President
Bradley Kreger
Senior Vice President
Brad Kreger
Other
Colin McCracken
Independent Director
Nicolas Barthelemy
Independent Director
Gerhard Burbach
Independent Director
Laura Clague
Independent Director
Bill Colston
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About FLDM
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Fluidigm Corporation stock information, including NASDAQ:FLDM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLDM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading FLDM stock methods without spending real money on the virtual paper trading platform.